Table 3.
Comparison of CrAg-Positive ART-Naïve and ART-Experienced PWH
| ` | CrAg-Positive ART-Naïve (N = 123) | CrAg-Positive ART-Experienced (n = 87) | Total (n = 210) | |
|---|---|---|---|---|
| No. (%) | No. (%) | No. (%) | P Valueb | |
| Sex (n = 85) | ||||
| Female | 26 (55.3) | 25 (65.8) | 51 (60.0) | .327 |
| Male | 21 (44.7) | 13 (34.2) | 34 (40.0) | |
| Level of health facility | ||||
| Health center III | 24 (19.5) | 10 (11.5) | 34 (16.2) | <.001a |
| Health center IV | 83 (67.5) | 20 (23.0) | 103 (49.0) | |
| Hospital | 16 (13.0) | 57 (65.5) | 73 (34.8) | |
| District | ||||
| Kassanda | 8 (6.5) | 4 (4.6) | 12 (5.7) | <.001a,b |
| Kiboga | 16 (13.0) | 12 (13.8) | 28 (13.3) | |
| Kyankwanzi | 1 (0.8) | 3 (3.4) | 4 (1.9) | |
| Luwero | 52 (42.3) | 10 (11.5) | 62 (29.5) | |
| Mityana | 16 (13.0) | 28 (32.2) | 44 (21.0) | |
| Mubende | 8 (6.5) | 15 (17.2) | 23 (11.0) | |
| Nakaseke | 11 (8.9) | 14 (16.1) | 25 (11.9) | |
| Nakasongola | 11 (8.9) | 1 (1.1) | 12 (5.7) | |
| Year | ||||
| 2018 | 71 (57.7) | 54 (62.1) | 125 (59.5) | .527 |
| 2019 | 52 (42.3) | 33 (37.9) | 85 (40.5) |
Abbreviations: ART, antiretroviral therapy; CrAg, cryptococcal antigen; PWH, people with HIV.
aStatistically significant result.
b P value from the Pearson chi-square test.
c P value from the Fisher exact test.